About NBR“Nightly Business Report produced by CNBC” (NBR) is an award-winning and highly-respected nightly business news program that airs on public television. Television’s longest-running evening business news broadcast, “NBR” features in-depth coverage and analysis of the biggest financial news stories of the day and access to some of the world’s top business leaders and policy makers.
- First-quarter GDP estimates could rise as February trade deficit narrows sharply
- Unpopularity contest: Trump is off to a historically poor start
- Treasury's Mnuchin is out of touch with reality on A.I.'s job-destroying potential, billionaire says
- These stocks should benefit if Trump combines an infrastructure plan with tax reform
- Opioid epidemic: Senate committee opens probe of five big painkiller makers
NBR on TwitterMy Tweets
Subscribe to RSS
There are buying opportunities in biotech and drug stocks despite the backlash from the repeal of Obamacare.
You have until Jan. 31 to buy medical coverage on the state and federal marketplaces.
Your health insurance may undergo a shakeup as Congress pushes ahead to unravel the Affordable Care Act. Get ready.
Give states the flexibility to tailor their own health care solutions, the Wisconsin Republican says.
Repealing Obamacare would provide a tax cut averaging $7 million for the 400 highest-earning taxpayers, according to a new study.
Competition is expected to cut a product’s price, but that hasn’t been the case for naloxone, a drug that reverses opioid overdoses.
The Obama administration starkly warned Republicans against a “repeal-and-delay” strategy on Obamacare.
Congress is moving to get rid of the Affordable Care Act, but hasn’t yet proposed a firm replacement for the health-care law.
The Republicans need to enact a replacement plan by the end of this year to ensure a clear transition, S&P’s Deep Banerjee says.
The tally is about 200,000 more than had signed up on the marketplace at this time last year.
Most retirees depend on Medicare, but it’s not a one-stop program, and it requires a lot of research. Here’s what you need to know.
After decades of victories in the battle against heart disease, health experts are now facing a stark truth: Progress has stalled.
Why visionaries Mazen and Jill Kamen believe their new foundation will finally fuel the cure for the deadliest childhood cancer in the US.
Nine states saw 10 to 13 percentage-point reductions in their adult uninsured rate from 2013 to 2015, according to the Commonwealth Fund.
Two senators are questioning a surge in price of a key drug made by Pfizer used to treat opioid overdoses.